...
首页> 外文期刊>European journal of anaesthesiology >Droperidol and dimenhydrinate alone or in combination for the prevention of post-operative nausea and vomiting after nasal surgery in male patients.
【24h】

Droperidol and dimenhydrinate alone or in combination for the prevention of post-operative nausea and vomiting after nasal surgery in male patients.

机译:单独使用氟哌利多和地苯海明合用或联合使用可预防男性患者鼻腔手术后的恶心和呕吐。

获取原文
获取原文并翻译 | 示例

摘要

Droperidol and dimenhydrinate are inexpensive antiemetic drugs. Droperidol, especially, has been studied extensively, but there are no studies on the combination of both drugs for prevention of post-operative nausea and vomiting. One hundred and forty male hospitalized patients undergoing nasal surgery were randomized to receive one of four anti-emetic regimes: placebo, dimenhydrinate (1 mg kg-1), droperidol (15 micrograms kg-1), or the combination of both drugs (droperidol 15 micrograms kg-1 + dimenhydrinate 1 mg kg-1) administered after induction of anaesthesia. Patients in the dimenhydrinate-group and the combination-group received a second dose of dimenhydrinate 6 h after the first administration to mitigate the short half-life of the drug. For general anaesthesia a standardized technique, including benzodiazepine premedication, propofol, desflurane in N2O/O2, vecuronium, and a continuous infusion of remifentanil, was used. Post-operative analgesia and anti-emetic rescue medication were standardized. Episodes of vomiting, retching, nausea, and the need for additional anti-emetics were recorded for 24 h. The main endpoint of this study was the number of patients who were completely free of post-operative nausea and vomiting (Fisher's Exact Test). Furthermore, the severity of post-operative nausea and vomiting was analysed using a standardized scoring algorithm. The incidence of patients completely free of post-operative nausea and vomiting was 62.9% in the placebo-group, 77.1% in the dimenhydrinate-group (P = 0.21), and 82.9% in the droperidol-group (P = 0.07). This increased to 94.3% in the combination-group (P = 0.0015). In all three treatment groups the severity of post-operative nausea and vomiting was reduced significantly compared with placebo treatment (P = 0.0003). The incidence of side effects was similar in the four groups. Dimenhydrinate was ineffective in reducing the incidence of post-operative nausea and vomiting and droperidol only reduced the severity of post-operative nausea and vomiting. However, the combination of both drugs significantly reduces the incidence of post-operative nausea and vomiting when compared with placebo treatment.
机译:氟哌利多和苯海拉明是廉价的止吐药。特别是,氟哌利多已经被广泛研究,但是尚无关于两种药物联合使用以预防术后恶心和呕吐的研究。一百四十名接受鼻腔手术的男性住院患者被随机分配接受以下四种止吐方案之一:安慰剂,苯海拉明(1 mg kg-1),氟哌利多(15微克kg-1)或两种药物的组合(氟哌利多麻醉诱导后给药15微克kg-1 +二氢海因酸盐1 mg kg-1)。地美海因组和联合治疗组中的患者在第一次给药后6小时接受了第二次地美海因的治疗,以减轻药物的短半衰期。对于全身麻醉,使用了标准化技术,包括苯二氮卓类药物,丙泊酚,N2O / O2中的地氟醚,维库溴铵和瑞芬太尼连续输注。术后镇痛和止吐药物已标准化。记录呕吐,呕吐,恶心和需要其他止吐药的情况持续24小时。这项研究的主要终点是完全没有术后恶心和呕吐的患者数量(Fisher's Exact Test)。此外,使用标准化评分算法分析了术后恶心和呕吐的严重程度。完全无术后恶心和呕吐的患者的发生率在安慰剂组中为62.9%,在苯海拉明组中为77.1%(P = 0.21),在氟哌利多组中为82.9%(P = 0.07)。在组合组中增加到94.3%(P = 0.0015)。与安慰剂治疗相比,在所有三个治疗组中,术后恶心和呕吐的严重程度均明显降低(P = 0.0003)。四组的副作用发生率相似。地苯海明在降低术后恶心和呕吐的发生率方面无效,而氟哌利多只能降低术后恶心和呕吐的严重程度。但是,与安慰剂治疗相比,两种药物的组合可显着降低术后恶心和呕吐的发生率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号